Frontiers in Pharmacology (Sep 2022)

Landscape of immune infiltration in entorhinal cortex of patients with Alzheimerʼs disease

  • Hui Zhang,
  • Hui Zhang,
  • Hui Zhang,
  • Hui Zhang,
  • Hui Zhang,
  • Silu Cao,
  • Silu Cao,
  • Silu Cao,
  • Silu Cao,
  • Silu Cao,
  • Yaru Xu,
  • Yaru Xu,
  • Yaru Xu,
  • Yaru Xu,
  • Yaru Xu,
  • Xiaoru Sun,
  • Xiaoru Sun,
  • Xiaoru Sun,
  • Xiaoru Sun,
  • Miaomiao Fei,
  • Miaomiao Fei,
  • Miaomiao Fei,
  • Miaomiao Fei,
  • Qi Jing,
  • Qi Jing,
  • Qi Jing,
  • Qi Jing,
  • Qi Jing,
  • Xiaodong Xu,
  • Xiaodong Xu,
  • Xiaodong Xu,
  • Xiaodong Xu,
  • Xiaodong Xu,
  • Jinxuan Tang,
  • Jinxuan Tang,
  • Jinxuan Tang,
  • Jinxuan Tang,
  • Bing Niu,
  • Cheng Li,
  • Cheng Li,
  • Cheng Li,
  • Cheng Li

DOI
https://doi.org/10.3389/fphar.2022.941656
Journal volume & issue
Vol. 13

Abstract

Read online

Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases and manifests as progressive memory loss and cognitive dysfunction. Neuroinflammation plays an important role in the development of Alzheimer’s disease and anti-inflammatory drugs reduce the risk of the disease. However, the immune microenvironment in the brains of patients with Alzheimer’s disease remains unclear, and the mechanisms by which anti-inflammatory drugs improve Alzheimer’s disease have not been clearly elucidated. This study aimed to provide an overview of the immune cell composition in the entorhinal cortex of patients with Alzheimer’s disease based on the transcriptomes and signature genes of different immune cells and to explore potential therapeutic targets based on the relevance of drug targets. Transcriptomics data from the entorhinal cortex tissue, derived from GSE118553, were used to support our study. We compared the immune-related differentially expressed genes (irDEGs) between patients and controls by using the limma R package. The difference in immune cell composition between patients and controls was detected via the xCell algorithm based on the marker genes in immune cells. The correlation between marker genes and immune cells and the interaction between genes and drug targets were evaluated to explore potential therapeutic target genes and drugs. There were 81 irDEGs between patients and controls that participated in several immune-related pathways. xCell analysis showed that most lymphocyte scores decreased in Alzheimer’s disease, including CD4+ Tc, CD4+ Te, Th1, natural killer (NK), natural killer T (NKT), pro-B cells, eosinophils, and regulatory T cells, except for Th2 cells. In contrast, most myeloid cell scores increased in patients, except in dendritic cells. They included basophils, mast cells, plasma cells, and macrophages. Correlation analysis suggested that 37 genes were associated with these cells involved in innate immunity, of which eight genes were drug targets. Taken together, these results delineate the profile of the immune components of the entorhinal cortex in Alzheimer’s diseases, providing a new perspective on the development and treatment of Alzheimer’s disease.

Keywords